Vaccinations Archive

A 2024 study found that two doses of the recombinant zoster vaccine to prevent shingles remains highly effective after four years.

Avoiding germs that cause respiratory and gastrointestinal illnesses is especially important during the winter months, when cases are on the rise. Learn which strategies keep you safe. 

Scientists are trying to create a vaccine that would protect people against all different strains of the influenza (flu) virus. These vaccines are being designed to target parts of the flu virus that don't change regularly and so are consistent across all strains. The perfect vaccine would also prevent symptoms (since current vaccines help prevent hospitalization and death, but not symptoms), and its effects would last for a lifetime. While such a vaccine is still many years away from reality, improved flu vaccines are expected in the meantime.

Who should get COVID vaccine boosters and when will remain in flux for at least another year. This summer, the FDA instructed the vaccine makers to have the next COVID vaccine target the XBB.1.5 Omicron subvariant. The CDC will be issuing specific recommendations by October, but infectious disease experts expect the newer vaccine to provide the most benefit for people over 65 and those younger with chronic conditions.

Learn which vaccines can help protect you against serious illness and hospitalization from RSV, COVID, and the flu this fall.

Tens of millions of people who've had COVID-19 suffer with persisting symptoms. The condition is called long COVID. Symptoms, such as fatigue, difficulty concentrating, and disrupted sleep, can seriously impair the ability to function at work and at home. Vaccines and antiviral drugs appear to offer some protection against getting long COVID. But more information is needed. The National Institutes of Health has committed over $1 billion to discover how to better diagnose, effectively treat, and ultimately prevent long COVID.

COVID-19 may increase the risk of cardiovascular problems, including heart attack, stroke, pulmonary embolism, atrial fibrillation, and heart failure, up to a year after the infection. But vaccination appears to lower these risks. Getting just one dose of a COVID vaccine may halve the risk of myocarditis, a rare condition that causes inflammation of the heart muscle that can arise after viral infections.

There are currently nine trials of vaccines for Alzheimer's disease under way. All of them are in people with mild Alzheimer's or with the pre-Alzheimer's condition called mild cognitive impairment. All of the vaccines are designed to encourage the immune system to remove protein deposits from the brain. Most experimental vaccines are given by injection; one being tested at Harvard Medical School uses a nasal spray. It will be several years before we know if any of them will work.

With influenza virus, a new vaccine must be developed each year to adapt to the virus's changing structure.